Literature DB >> 12471563

Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy.

Claudia Thomas1, Mark Stevenson, D James Williamson, Thomas V Riley.   

Abstract

The incidence of Clostridium difficile-associated diarrhea (CDAD) has increased dramatically in hospitals worldwide during the past 2 decades. In Western Australia, this increase was most obvious during the 1980s, when there was also an increase in the use of third-generation cephalosporin antibiotics. A study of the epidemiology of CDAD and the use of third-generation cephalosporins during 1993-2000 was undertaken. From 1993 through 1998, the incidence of CDAD remained relatively stable (2-3 cases per 1000 discharges annually). Then, a significant decrease in the incidence occurred, from 2.09 cases per 1000 discharges (95% confidence interval [CI], 1.71-2.47) in 1998 to 0.87 cases per 1000 discharges (95% CI, 0.63-1.11) in 1999 (P<.0001); this decrease persisted into 2000. A decrease in third-generation cephalosporin use occurred during the period of the study because of changes in the prescribing policy. These findings suggest that a reduction in the use of third-generation cephalosporins can reduce the occurrence of CDAD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471563     DOI: 10.1086/342691

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

Review 1.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

Review 2.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

Review 3.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them.

Authors:  Bhaskar Thakuria; Kingshuk Lahon
Journal:  J Clin Diagn Res       Date:  2013-06-01

Review 5.  Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.

Authors:  Fawziah Marra; Karen Ng
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

6.  Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Authors:  T Norén; T Akerlund; E Bäck; L Sjöberg; I Persson; I Alriksson; L G Burman
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  [Community-acquired and nosocomial pneumonia].

Authors:  T Welte
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

Review 8.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

9.  Descriptive epidemiology of infectious gastrointestinal illnesses in Sydney, Australia, 2007-2010.

Authors:  Stephanie Fletcher; David Sibbritt; Damien Stark; John Harkness; William Rawlinson; David Andresen; Sebastian Van Hal; Juan Merif; John Ellis
Journal:  Western Pac Surveill Response J       Date:  2015-10-06

10.  Does doxycycline protect against development of Clostridium difficile infection?

Authors:  Sarah B Doernberg; Lisa G Winston; Daniel H Deck; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2012-05-04       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.